EOLS
Evolus Inc
NASDAQ: EOLS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.18
-1.71% today
Updated 2026-04-29
Market cap
$344.82M
P/E ratio
—
P/S ratio
1.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$4 – $12
Volume
1.1M
Evolus Inc (EOLS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-100.0%
Last 4 quarters
Revenue YoY growth
+14.4%
Most recent quarter
EPS YoY growth
-5.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+21.2%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+30.3%
2026-03-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $0.01 | -64.6% | $4.29 | $5.59 | +30.3% |
| 2025-11-05 | $-0.24 | -60.0% | $6.41 | $7.18 | +12.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.04 | $0.01 | -64.6% | $90.30M | +14.4% |
| 2025-09-30 | $-0.15 | $-0.24 | -60.0% | $68.97M | +12.9% |
| 2025-06-30 | $-0.10 | $-0.27 | -170.0% | $69.39M | +3.7% |
| 2025-03-31 | $-0.10 | $-0.17 | -70.0% | $68.52M | +15.5% |
| 2024-12-31 | $0.02 | $0.01 | -37.7% | $78.95M | +29.4% |
| 2024-09-30 | $-0.10 | $-0.16 | -60.0% | $61.09M | +22.1% |
| 2024-06-30 | $-0.05 | $-0.04 | +20.0% | $66.91M | +35.6% |
| 2024-03-31 | $-0.10 | $-0.09 | +10.0% | $59.33M | +42.2% |
| 2023-12-31 | $-0.07 | $-0.12 | -71.4% | $61.00M | — |
| 2023-09-30 | $-0.17 | $-0.16 | +5.9% | $50.02M | — |
| 2023-06-30 | $-0.19 | $-0.19 | +0.0% | $49.35M | — |
| 2023-03-31 | $-0.15 | $-0.15 | +0.0% | $41.72M | — |
Frequently asked questions
Has Evolus Inc beaten earnings estimates?
Evolus Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -100.0% over the last 3 quarters.
How does EOLS stock react to earnings?
EOLS stock has moved an average of +21.2% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Evolus Inc's revenue growth rate?
Evolus Inc reported year-over-year revenue growth of +14.4% in its most recent quarter, with EPS growing -5.0% year-over-year.